drugset / Trial / NCT00010010
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
Treatment
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using exemestane plus goserelin may fight breast cancer by reducing the production of estrogen. PURPOSE: Phase II trial to study the effectiveness of exemestane and goserelin in treating premenopausal women who have metastatic breast cancer that has not responded to previous tamoxifen.
Timeline
- Start
- 2000-06
- Primary completion
- 2001-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exemestane | Small molecule | — | Oral |
| Subject | Goserelin | Other / unclassified | — | Subcutaneous |